Lucid Diagnostics (LUCD) Shares Outstanding (2022 - 2025)
Historic Shares Outstanding for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $130.9 million.
- Lucid Diagnostics' Shares Outstanding rose 15374.12% to $130.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.9 million, marking a year-over-year increase of 15374.12%. This contributed to the annual value of $63.1 million for FY2024, which is 4900.11% up from last year.
- According to the latest figures from Q3 2025, Lucid Diagnostics' Shares Outstanding is $130.9 million, which was up 15374.12% from $101.8 million recorded in Q2 2025.
- In the past 5 years, Lucid Diagnostics' Shares Outstanding registered a high of $130.9 million during Q3 2025, and its lowest value of $35.2 million during Q1 2022.
- For the 4-year period, Lucid Diagnostics' Shares Outstanding averaged around $56.3 million, with its median value being $42.3 million (2023).
- In the last 5 years, Lucid Diagnostics' Shares Outstanding soared by 446.97% in 2023 and then skyrocketed by 15374.12% in 2025.
- Lucid Diagnostics' Shares Outstanding (Quarter) stood at $40.5 million in 2022, then grew by 4.47% to $42.3 million in 2023, then surged by 49.0% to $63.1 million in 2024, then skyrocketed by 107.58% to $130.9 million in 2025.
- Its last three reported values are $130.9 million in Q3 2025, $101.8 million for Q2 2025, and $84.4 million during Q1 2025.